ClinicalTrials.gov
public full text
Public Domain
Gene Therapy Study for Children With CLN5 Batten Disease
This is a prospective, non-randomized, open-label, dose escalation study of a single administration of gene therapy in children who are 3 to 9 years old with Neuronal Ceroid Lipofuscinosis (Batten) Subtype 5 (CLN5) disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study for the Treatment for CLN7 Disease#1060656
- Safety and Efficacy of Injectable Klotho Plasmid Gene Therapy in Humans#837272
- Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products#683131
- A Study for Patients With Relapsing Remitting Multiple Sclerosis#1074246
- Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies#1086229
Record · ID 803687
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive